If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...

Novo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different ...

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

While more research is necessary, some evidence suggests ginger may help manage blood sugar levels. As such, people with diabetes can safely consume ginger as part of a balanced eating plan ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose weight—without the nauseating symptoms now commonly seen with GLP-1 drugs.

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 ...

After an intense workout, flopping onto the couch might seem like the best option. But many people swear by light movement after exercise to reduce soreness and speed up recovery. But does it actually ...

Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row NovoCare, which partners with CenterWell Pharmacy for fulfillment, is part of Novo’s response to the cheaper compounded ...

These GLP-1 agonists include semaglutide, liraglutide, and dulaglutide, now marketed as Ozempic, Wegovy, Saxenda, Victoza, and Trulicity. It remained unclear, however, whether physicians should ...

The percentage of patients with no insurance coverage taking the GLP-1 drugs Victoza, Saxenda, Zepbound and Ozempic increased just between January and November, according to a report from drug ...